Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jeff M. Holzbeierlein"'
Autor:
Petros Grivas, Peter C. Black, Scott North, Marc A. Dall'Era, Laura Maria Krabbe, Colin P.N. Dinney, Laura S. Mertens, Jeff M. Holzbeierlein, Niels Jacobsen, Yair Lotan, Jo An Seah, Francesco Soria, Adrian Fairey, Homayoun Zargar, Nicholas J. Campain, Jonathan L. Wright, Cesar E. Ercole, Nikhil Vasdev, Shahrokh F. Shariat, Daniel A. Barocas, Andrew C. Thorpe, Srikala S. Sridhar, Simon Horenblas, Michael S. Cookson, Bas W.G. van Rhijn, Jay B. Shah, Todd M. Morgan, David D'Andrea, Jeffrey S. Montgomery, Evanguelos Xylinas, Philippe E. Spiess, Evan Y. Yu, Wassim Kassouf, John S. McGrath, Trinity J. Bivalacqua, Kamran Zargar-Shoshtari, Jonathan Aning, Andrew J. Stephenson, Maria Carmen Mir, Siamak Daneshmand
Publikováno v:
World Journal of Urology
Purpose To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC). Materials and methods We analyzed data from 1105 patients with MIBC. Patients age was evaluated as con
Autor:
Scott North, Shahrokh F. Shariat, Trinity J. Bivalacqua, Michael S. Cookson, Andrew C. Thorpe, Diego M Carrion, Philippe E. Spiess, Ettore Di Trapani, Yair Lotan, Homayoun Zargar, Jonathan L. Wright, Jeffrey S. Montgomery, Wassim Kassouf, John S. McGrath, Colin P.N. Dinney, Daniel A. Barocas, Marc A. Dall'Era, Jeff M. Holzbeierlein, Peter C. Black, Francesco Soria, Bas W.G. van Rhijn, Srikala S. Sridhar, Siamak Daneshmand, Petros Grivas, David D'Andrea, Andrew J. Stephenson
Publikováno v:
The Journal of urology. 207(1)
We investigated the pathological response rates and survival associated with 3 vs 4 cycles of cisplatin-based neoadjuvant chemotherapy (NAC) in patients with cT2-4N0M0 muscle invasive bladder cancer.In this cohort study we analyzed clinical data of 8
Autor:
Siamak Daneshmand, Yair Lotan, Marc A. Dall'Era, Homayoun Zargar, Wassim Kassouf, John S. McGrath, Nilay M. Gandhi, Jeff M. Holzbeierlein, Andrew C. Thorpe, Jeffrey S. Montgomery, Jonathan L. Wright, Philippe E. Spiess, Niels Jacobsen, Simon Horenblas, Michael S. Cookson, Joshua Griffin, Maria Carmen Mir, Daniel A. Barocas, Andrew J. Stephenson, Peter C. Black, Evanguelos Xylinas, Jonathan Aning, Adrian Fairey, Scott North, Patrick Espiritu, Laura Maria Krabbe, Todd M. Morgan, Colin P.N. Dinney, Laura S. Mertens, Trinity J. Bivalacqua, David Youssef, Shahrokh F. Shariat, Cesar E. Ercole, Jorge A. Garcia, Bas W.G. van Rhijn, Jay B. Shah, Jo An Seah, Srikala S. Sridhar, Evan Y. Yu, Nikhil Vasdev, Nicholas J. Campain
Publikováno v:
Europe PubMed Central
The efficacy of neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (BCa) was established primarily with methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC), with complete response rates (pT0) as high as 38%. However, because o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b535496654d6924d03248f472a02c35
http://europepmc.org/abstract/med/25257030
http://europepmc.org/abstract/med/25257030